IXICO plc (FRA:PYPB)

Market Cap	11.60M
Revenue (ttm)	7.69M
Net Income (ttm)	-1.85M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1100
Previous Close	0.1080
Day's Range	0.1100 - 0.1100
52-Week Range	0.0830 - 0.1600
Beta	n/a
RSI	41.35
Earnings Date	Dec 9, 2025

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis ...

• Industry: Medicinal Chemicals and Botanical Products
• CEO: Bram Goorden
• Employees: 81
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PYPB

Financial Performance

In 2024, IXICO's revenue was 5.77 million, a decrease of -13.49% compared to the previous year's 6.67 million. Losses were -2.00 million, 69.9% more than in 2023.

Financial numbers in GBP